Cohort of patients with acute hidrosadenitis in the Great West
Official title: Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)
Run by Nantes University Hospital · NCT04352036 · Data updated 2026-11-12
This study follows people with acute hidrosadenitis to see how the condition shows up in different ways, which could help improve treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 465 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 13 sites (Angers and 12 other locations) |
| Status | Recruiting |
| Started | January 4, 2022 |
| Main results expected | February 20, 2030 |
| Study ends | February 20, 2030 |
| Registry record updated | September 5, 2025 |
| Trial ID | NCT04352036 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients diagnosed with acute hidrosadenitis by a dermatologist who are willing to participate in the study.
✕Probably not a fit
Patients without social security affiliation or those under guardianship may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort aims to define the various phenotypes of acute hidrosadenitis to better understand the condition and tailor therapeutic approaches. By following patients diagnosed with this condition, the study seeks to gather data that will help characterize the different manifestations of acute hidrosadenitis. The insights gained could lead to improved management and treatment strategies for affected individuals.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective treatment options for patients with acute hidrosadenitis.
How similar studies have gone: While this approach is observational and focuses on phenotype characterization, similar studies in other conditions have shown that understanding different disease manifestations can lead to significant advancements in treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient diagnosed with acute hidrosadenitis by a dermatologist * Patient agreeing to be part of the study Exclusion Criteria: * Major under guardianship * Protected persons
Where it's running
-
CHU Angers
Angers, France Recruiting -
Chru Brest
Brest, France Recruiting -
CHD Vendée
La Roche-sur-Yon, France Recruiting -
CH La Rochelle
La Rochelle, France Recruiting -
Ch
Le Mans, France Recruiting -
CH bretagne sud
Lorient, France Recruiting
Show 7 more locations
-
CHU de Nantes - Dermatologie
Nantes, France Recruiting -
Chr D'Orléans
Orléans, France Recruiting -
CHU Milétrie
Poitiers, France Recruiting -
Ch de Cornouaille
Quimper, France Recruiting -
CHU Pontchaillou
Rennes, France Recruiting -
Ch Saint-Brieuc
Saint-Brieuc, France Recruiting -
CHRU Tours
Tours, France Recruiting
Study contacts
- Study coordinator: Brigitte Dreno, PU-PH
- Email: brigitte.dreno@wanadoo.fr
- Phone: 0240083118
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.